One in five pregnant substance users reported using more than one substance during pregnancy

Among US pregnant women who used any substance, nearly 20% reported polysubstance use, with cannabis at 4.3% prevalence and screening rates for cannabis lagging behind alcohol and tobacco.

Board, Amy et al.·Drug and alcohol dependence·2023·Strong EvidenceCross-Sectional
RTHC-04421Cross SectionalStrong Evidence2023RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Cross-Sectional
Evidence
Strong Evidence
Sample
Not reported

What This Study Found

In a nationally representative US sample, cigarettes (8.1%), alcohol (7.4%), and cannabis (4.3%) were the most commonly reported substances during pregnancy. Among those using any substance, nearly one in five used at least one additional substance. While prenatal screening for alcohol and cigarettes reached ~95%, only 82.1% were screened for cannabis or illicit substances.

Key Numbers

Cigarettes: 8.1% (95% CI 7.6-8.7%); alcohol: 7.4% (95% CI 6.7-8.1%); cannabis: 4.3% (95% CI 3.9-4.7%); illicit drugs: 0.5% (95% CI 0.4-0.7%); cannabis screening: 82.1%; alcohol/tobacco screening: ~95%

How They Did This

Analysis of 2019 Pregnancy Risk Assessment Monitoring System (PRAMS) data from 25 US jurisdictions. Weighted prevalence estimates calculated for substance use, polysubstance use, and screening rates during pregnancy.

Why This Research Matters

The gap between high screening rates for alcohol/tobacco and lower rates for cannabis suggests clinicians may be missing a meaningful proportion of prenatal substance exposure, particularly given rising cannabis legalization.

The Bigger Picture

As cannabis use during pregnancy increases alongside legalization, the 13-percentage-point gap in screening rates compared to alcohol and tobacco represents a growing blind spot in prenatal care.

What This Study Doesn't Tell Us

Self-reported substance use likely underestimates true prevalence. PRAMS data from 25 jurisdictions may not represent all US states. Different assessment windows for different substances complicate direct comparisons.

Questions This Raises

  • ?Would universal cannabis screening during pregnancy improve detection and intervention rates?
  • ?How does polysubstance use affect neonatal outcomes compared to single-substance exposure?

Trust & Context

Key Stat:
82% screened for cannabis vs. 95% for alcohol and tobacco
Evidence Grade:
Nationally representative surveillance data from 25 US jurisdictions with weighted estimates, though self-reported substance use likely underestimates prevalence.
Study Age:
Published 2023 using 2019 data
Original Title:
Polysubstance use during pregnancy: The importance of screening, patient education, and integrating a harm reduction perspective.
Published In:
Drug and alcohol dependence, 247, 109872 (2023)
Database ID:
RTHC-04421

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

A snapshot of a population at one point in time.

What do these levels mean? →

Frequently Asked Questions

How common is cannabis use during pregnancy in the US?

According to this nationally representative survey, 4.3% of pregnant women reported cannabis use, making it the third most common substance after cigarettes (8.1%) and alcohol (7.4%).

Are pregnant women screened for cannabis use?

About 82% of pregnant women reported being screened for cannabis or illicit substances, compared to approximately 95% being screened for alcohol and cigarettes.

Read More on RethinkTHC

Cite This Study

RTHC-04421·https://rethinkthc.com/research/RTHC-04421

APA

Board, Amy; D'Angelo, Denise V; Salvesen von Essen, Beatriz; Denny, Clark H; Miele, Kathryn; Dunkley, Janae; Baillieu, Robert; Kim, Shin Y. (2023). Polysubstance use during pregnancy: The importance of screening, patient education, and integrating a harm reduction perspective.. Drug and alcohol dependence, 247, 109872. https://doi.org/10.1016/j.drugalcdep.2023.109872

MLA

Board, Amy, et al. "Polysubstance use during pregnancy: The importance of screening, patient education, and integrating a harm reduction perspective.." Drug and alcohol dependence, 2023. https://doi.org/10.1016/j.drugalcdep.2023.109872

RethinkTHC

RethinkTHC Research Database. "Polysubstance use during pregnancy: The importance of screen..." RTHC-04421. Retrieved from https://rethinkthc.com/research/board-2023-polysubstance-use-during-pregnancy

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.